537. Safety and Effectiveness of Ensitrelvir for the Treatment of COVID-19 in Japanese Clinical Practice: A Post-marketing Surveillance (Interim Analysis)

BACKGROUND: Ensitrelvir fumaric acid (ensitrelvir) is a novel anti-SARS-CoV-2 drug and an inhibitor of SARS-CoV-2 3CL protease. Emergency regulatory approval was obtained in Japan in November 2022. Post-marketing surveillance (PMS) is currently on-going to evaluate safety and effectiveness of ensitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogura, Eriko, Nakagawa, Noriko, Hayashi, Noriko, Tsukimura, Eri, Takashima, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678592/
http://dx.doi.org/10.1093/ofid/ofad500.606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678592/
http://dx.doi.org/10.1093/ofid/ofad500.606

Ejemplares similares